Mixed COVID-19 Vaccine Study Launches

In COVID-19, Latest News by Precision Vaccinations

The US National Institutes of Health has announced the launch of a Phase 1/2 clinical trial. Adult volunteers who have been fully vaccinated against COVID-19 will receive booster doses of different COVID-19 vaccines to determine the safety and immunogenicity of mixed boosted regimens.
This vaccine study will include approximately 150 individuals who already have received one of the three COVID-19 vaccine regimens currently available under FDA Emergency Use Authorization in the USA.

Read More